Review of von Willebrand Disease and Acquired von Willebrand Syndrome for Patients Undergoing Cardiac Surgery

被引:6
作者
Berger, Jay [1 ]
Schwartz, Joseph [1 ]
Ramachandran, Sujatha [1 ]
Leff, Jonathan D. [1 ]
机构
[1] Montefiore Hosp & Med Ctr, Dept Anesthesiol, Bronx, NY USA
关键词
von Willebrand disease; vWD; von Willebrand factor; vWF; cardiac surgery; acquired von Willebrand syndrome; ABO BLOOD-GROUP; NORMAL PLATELET TRANSFUSION; VENTRICULAR ASSIST DEVICES; BLEEDING ASSESSMENT-TOOL; FACTOR-VIII; ADVERSE EVENTS; HEMOPHILIA-A; DESMOPRESSIN; DIAGNOSIS; MANAGEMENT;
D O I
10.1053/j.jvca.2019.08.025
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:3446 / 3457
页数:12
相关论文
共 82 条
[21]   Successful Coronary Artery Bypass in Types 2M and 2N von Willebrand Disease [J].
Fiore, Mathieu ;
Tuffigo, Marie ;
Cahoreau, Veronique ;
Oses, Pierre ;
Mouton, Christine .
ANNALS OF THORACIC SURGERY, 2016, 102 (05) :E423-E425
[22]   A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor [J].
Gallinaro, Lisa ;
Cattini, Maria Grazia ;
Sztukowska, Maryta ;
Padrini, Roberto ;
Sartorello, Francesca ;
Pontara, Elena ;
Bertornoro, Antonella ;
Daidone, Viviana ;
Pagnan, Antonio ;
Casonato, Alessandra .
BLOOD, 2008, 111 (07) :3540-3545
[23]   Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease [J].
Geisen, Ulrich ;
Heilmann, Claudia ;
Beyersdorf, Friedhelm ;
Benk, Christoph ;
Berchtold-Herz, Michael ;
Schlensak, Christian ;
Budde, Ulrich ;
Zieger, Barbara .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 33 (04) :679-684
[24]  
GILL JC, 1987, BLOOD, V69, P1691
[25]   Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease [J].
Gill, Joan C. ;
Castaman, Giancarlo ;
Windyga, Jerzy ;
Kouides, Peter ;
Ragni, Margaret ;
Leebeek, Frank W. G. ;
Obermann-Slupetzky, Ortrun ;
Chapman, Miranda ;
Fritsch, Sandor ;
Pavlova, Borislava G. ;
Presch, Isabella ;
Ewenstein, Bruce .
BLOOD, 2015, 126 (17) :2038-2046
[26]   Pharmacokinetic studies on Wilfactin®, a von Willebrand factor concentrate with a low factor VIII content treated with three virus-inactivation/removal methods [J].
Goudemand, J ;
Scharrer, I ;
Berntorp, E ;
Lee, CA ;
Borel-Derlon, A ;
Stieltjes, N ;
Caron, C ;
Scherrmann, JM ;
Bridey, F ;
Tellier, Z ;
Federici, AB ;
Mannucci, PM .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (10) :2219-2227
[27]   Current and Emerging Options for the Management of Inherited von Willebrand Disease [J].
Heijdra, Jessica M. ;
Cnossen, Marjon H. ;
Leebeek, Frank W. G. .
DRUGS, 2017, 77 (14) :1531-1547
[28]   Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II [J].
Heilmann, Claudia ;
Trummer, Georg ;
Beyersdorf, Friedhelm ;
Brehm, Kerstin ;
Berchtold-Herz, Michael ;
Schelling, Johannes ;
Geisen, Ulrich ;
Zieger, Barbara .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2017, 51 (03) :587-590
[29]   Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS) [J].
Heilmann, Claudia ;
Geisen, Ulrich ;
Beyersdorf, Friedhelm ;
Nakamura, Lea ;
Benk, Christoph ;
Trummer, Georg ;
Berchtold-Herz, Michael ;
Schlensak, Christian ;
Zieger, Barbara .
INTENSIVE CARE MEDICINE, 2012, 38 (01) :62-68
[30]   Coagulation and Bleeding Management in Pediatric Extracorporeal Membrane Oxygenation: Clinical Scenarios and Review [J].
Hensch, Lisa A. ;
Hui, Shiu-Ki Rocky ;
Teruya, Jun .
FRONTIERS IN MEDICINE, 2019, 5